Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

Novo Nordisk to Replace C.E.O. After Losing Edge in Weight-Loss Drugs

The Danish drugmaker, which makes Ozempic and Wegovy, has seen its stock tumble as competition in the weight-loss drug market has grown fiercer.

Rebecca Robbins
Author: Rebecca Robbins

Written by

Rebecca Robbins

in

Appointments and Executive Changes, Drugs (Pharmaceuticals), GLP-1 RAs (Drug), Jorgensen, Lars Fruergaard, Novo Nordisk A/S, Ozempic (Drug), Stocks and Bonds
←Why Everything Is ‘Coded’ Now
Who Took the ‘Napalm Girl’ Photo?→

More posts

  • Thriller ‘Games We Play’, With ‘Riverdale’ Star Casey Cott, Heads To AFM & Gets North American Release

  • Martha Stewart’s Charity Says It Doesn’t Serve Homeless After Costume Uproar

  • Judge rejects charges against former FBI agents who worked on the Hunter Biden case

  • Hulk Hogan’s Widow Sky Daily Insists She’s Not A Scientologist

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube